Anthropic commits 5% of shares to new public benefit fund

President Trump's Push to Reschedule Marijuana Hit a Snag. Is Green Thumb Still a Buy?

NASDAQ · Markets 54m ago

Wall Street's AI Boom Just Reached a Dangerous Milestone. History Says the Winners Could Change.

NASDAQ · Markets 1h ago

European earnings preview: Can Q3 results meet high expectations?

Investing.com · News 1h ago

Should You Buy Costco Stock Before Oct. 30? Here's the Clear Answer.

NASDAQ · Markets 1h ago

The 2027 Social Security COLA Will Boost Average Benefits by $901 Annually. Will It Be Enough?

NASDAQ · Markets 1h ago

Coca-Cola Yields 2.3% and Nike Yields 4.4%. Here's Why Only 1 of These High-Yield Dividend Stocks Is a Buy This October.

NASDAQ · Markets 1h ago

Gilead Sciences Is on an FDA Approval Hot Streak. Should You Buy the Stock Like There's No Tomorrow?

NASDAQ · Markets 2h ago

State Street: 3 Key Takeaways for Long-Term Investors

NASDAQ · Markets 2h ago

ASML is the Most Important Company in the AI Ecosystem, and It Just Delivered Record Results. Here’s Where the Stock Will Be in 2028

NASDAQ · Markets 2h ago

History Says Nvidia Stock Does This in November. Here's the 1 Thing That Could Break the Pattern.

NASDAQ · Markets 2h ago